PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
29.95%
Revenue growth of 29.95% vs. zero growth in Insurance - Life. Walter Schloss might still want to see if it can translate into profits.
29.95%
Gross profit growth of 29.95% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that could be built upon.
-287.77%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-287.77%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-308.60%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-308.62%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-308.59%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
27.76%
OCF growth exceeding 1.5x Insurance - Life median of 5.01%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
27.76%
FCF growth exceeding 1.5x Insurance - Life median of 5.01%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
233.81%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 74.71%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
49.05%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 15.16%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
63.26%
3Y CAGR of 63.26% while Insurance - Life median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
301.86%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 71.97% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
71.51%
OCF/share CAGR of 71.51% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
36.47%
3Y OCF/share growth of 36.47% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-1078.63%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 57.51%. Seth Klarman might see a fundamental problem if peers maintain growth.
-382.20%
Negative 5Y CAGR while Insurance - Life median is -2.78%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-316.20%
Negative 3Y CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
272.66%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 13.04% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
15.04%
5Y equity/share CAGR > 1.5x Insurance - Life median of 5.53%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
8.95%
3Y equity/share CAGR of 8.95% while Insurance - Life median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.94%
Asset growth exceeding 1.5x Insurance - Life median of 2.10%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
-5.19%
Negative BV/share change while Insurance - Life median is 0.00%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-0.31%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
1.00%
SG&A growth of 1.00% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.